Venture Life Group (LON:VLG) Stock Passes Above 50-Day Moving Average – Should You Sell?

Venture Life Group plc (LON:VLG) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 64.71 and traded as high as GBX 70. Venture Life Group shares last traded at GBX 69.50, with a volume of 302,650 shares trading hands.

Venture Life Group Stock Performance

The company has a 50 day moving average of GBX 64.71 and a two-hundred day moving average of GBX 65.34. The company has a debt-to-equity ratio of 0.82, a current ratio of 4.71 and a quick ratio of 1.48. The company has a market capitalization of £84.31 million, a PE ratio of 15.90, a PEG ratio of 5.67 and a beta of 0.22.

Insider Activity at Venture Life Group

In other Venture Life Group news, insider Paul McGreevy bought 93,887 shares of the company’s stock in a transaction dated Tuesday, June 30th. The shares were purchased at an average price of GBX 64 per share, for a total transaction of £60,087.68. In the last quarter, insiders have acquired 174,094 shares of company stock worth $11,012,928. Insiders own 7.45% of the company’s stock.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.